References

  1. Finfer S, Bellomo R, Lipman J, French C, Dobb G, Myburgh J et al. Adult population incidence of severe sepsis in Australian and New Zealand Intensive Care Units. Intensive Care Med 2004;30:589-96.
  2. Martin GS, Mannino DM, Eaton S, Moss M. The Epidemiology of Sepsis in the United States from 1979 through 2000. New England J Med 2003;348:1546-1554.
  3. Kaukonen K, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 2014;311:1308-16.
  4. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007;35:1244-50.
  5. Liu V, Escobar GJ, Greene JD, Soule J, Whippy A, Angus DC et al. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA 2014;312:90-2.
  6. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-96.
  7. Ferrer R, Artigas A, Levy MM, Blanco J, Gonzalez-Diaz G, Garnacho-Montero J et al. Improvement in Process of Care and Outcome After a Multicenter Severe Sepsis Educational Program in Spain. JAMA 2008;299:2294-303.
  8. Levy M, Dellinger RP, Townsend S, Linde-Zwirble WT, Marshall J, Bion J et al. The surviving Sepsis campaign: Results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med. 2010;38:367-74
  9. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013;39:165-228.